6,300
Views
149
CrossRef citations to date
0
Altmetric
Review Article

Obesity and metabolic syndrome: Association with chronodisruption, sleep deprivation, and melatonin suppression

, , &
Pages 564-577 | Received 22 Mar 2011, Accepted 26 Apr 2011, Published online: 10 Sep 2012

References

  • Wang Y, Beydoun MA, Liang L, Caballero B, Kumanyika SK. Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity. 2008;16:2323–30.
  • Kuczmarski RJ, Flegal KM. Criteria for definition of overweight in transition: background and recommendations for the United States. Am J Clin Nutr. 2000;72:1074–81.
  • Kelly T, Wang W, Chen CS, Reynolds K, He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes. 2008;32:1431–7.
  • Ogden CL, Flegal KM, Carrall MD, Johnson CL. Prevalence and trends in overweight among US children and adolescents 1999–2000. J Am Med Assoc. 2002;288:1728–32.
  • Haslam DW, James WP. Obesity. Lancet. 2005;366: 1197–209.
  • De Pauw A, Tejerina S, Raes M, Keijeo J, Arnould T. Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations. Am J Pathol. 2009;175: 927–39.
  • Korkmaz A, Topal T, Tan DX, Reiter RJ. Role of melatonin in metabolic regulation. Rev Endocr Metab Disord. 2009;10:261–70.
  • Azagury DE, Lautz DB. Obesity overview: epidemiology, health and financial impact, and guidelines for qualification for surgical therapy. Gastrointest Endosc Clin N Am. 2011; 21:189–201.
  • Reiter RJ, Tan DX, Erren TC, Fuentes-Broto L, Paredes SD. Light-mediated perturbations of circadian timing and cancer risk: a mechanistic analysis. Integr Cancer Ther. 2009;8: 354–60.
  • Tan DX, Manchester LC, Fuentes-Broto L, Paredes SD, Reiter RJ. Significance and application of melatonin in the regulation of brown adipose tissue metabolism: relation to human obesity. Obes Rev. 2011;12:167–88.
  • Turek FW, Joshu C, Kohsaka A, Lin E, Ivanova G, McDearmon E, . Obesity and metabolic syndrome in circadian Clock mutant mice. Science. 2005;308:1043–5.
  • Alonso-Vale MIC, Andreotti S, Mukai PY, Borges-Silva CN, Peres SB, Cipolla-Neto J, . Melatonin and circadian entrainment of metabolic and hormonal activities in primary isolated adipocytes. J Pineal Res. 2008;45:422–9.
  • Van Cauter E, Knutson KL. Sleep and the epidemic of obesity in children and adults. Eur J Endocrinol. 2008;159:S59–66.
  • Erren TC, Reiter RJ. Chronodisruption. J Pineal Res. 2009;46:45–7.
  • Garaulet M, Madrid JA. Chronobiology, genetics and metabolic syndrome. Curr Opin Lipidol. 2009;20:127–34.
  • Green CB, Takahashi J, Bass J. The meter of metabolism. Cell. 2008;134:728–42.
  • Reiter RJ. The melatonin rhythm: both a clock and a calendar. Experientia. 1993;49:654–64.
  • Reiter RJ. Melatonin: the chemical expression of darkness. Mol Cell Endocrinol. 1991;79:C153–9.
  • Reiter RJ. Pineal control of a seasonal reproductive rhythm in male golden hamsters exposed to natural daylight and temperature. Endocrinology. 1973;92:423–30.
  • Jasser SA, Blask DE, Brainard GC. Light during darkness and cancer: relationships in circadian photoreception and tumor biology. Cancer Causes Control. 2006;17:515–23.
  • Duffy JF, Czeisler CA. Effect of light on human circadian physiology. Sleep Med Clin. 2009;4:165–77.
  • Reiter RJ, Tan DX, Korkmaz A, Erren TC, Piekarski C, Tamura H, . Light at night, chronodisruption, melatonin suppression, and cancer risk: a review. Crit Rev Oncogen. 2007;13:303–28.
  • Stevens RG, Blask DE, Brainard GC, Hansen J, Lockley SW, Provencio I, . Meeting report: the role of environmental lighting and circadian disruption in cancer and other diseases. Environ Health Perspect. 2007;115:1357–62.
  • Erren TC, Pope HC, Reiter RJ, Pieksarski C. Chronodisruption and cancer. Naturwissenschaften. 2008;95:367–82.
  • Blask DE. Melatonin, sleep disturbance and cancer risk. Sleep Med Rev. 2009;13:257–64.
  • Pezuk P, Mohawk JA, Yoshikawa T, Sellix MT, Menaker M. Circadian organization is governed by extra-SCN pacemakers. J Biol Rhythms. 2010;25:432–41.
  • Zee PC, Goldstein CA. Treatment of shift work disorder and jet lag. Curr Treat Options Neurol. 2010;12:396–411.
  • Arendt J. Jet lag. Lancet. 1998;357:293–4.
  • Bass J, Takahashi JS. Circadian integration of metabolism and energetics. Science. 2010;330:1349–54.
  • Wozniak SE, Gee LL, Wachtel MS, Frezza EE. Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci. 2009;94:1847–56.
  • Zac-Varghese S, Tan T, Bloom SR. Hormonal interactions between gut and brain. Discov Med. 2010;10:543–52.
  • Aoyagi T, Shimba S, Tezuka M. Characteristics of circadian gene expression in mice white adipose tissue and 3T3-L1 adipocytes. J Health Sci. 2005;51:2132.
  • Ptitsyn AA, Zvonic S, Conrad SA, Scott LK, Mynatt RL, Amble JM. Circadian clocks are resounding in peripheral tissues. PLoS Comput Biol. 2006;2:e16.
  • Gomez-Santos P, Gomez-Abellan JA, Madrid JA, Hernandez-Morante JJ, Lujan JA, Ordovas JM, . Circadian rhythm of clock genes in human adipose explants. Obesity. 2009;17:1481–5.
  • Srinivasan V, Singh J, Pandi-Perumal SR, Brown GM, Spence DW, Cardinali DP. Jet lag, circadian rhythm sleep disturbances and depression: the role of melatonin and its analogue. Adv Ther. 2010;27:796–813.
  • Garaulet M, Ordovas JM, Gomez-Abellan P, Martinez JA, Madrid JA. An approximation to the temporal order in endogenous circadian rhythms of genes implicated in human adipose tissue metabolism. J Cell Physiol. 2011;226:2075–80.
  • Karlsson B, Knutson B, Lindhl B. Is there an association between shift work and having a metabolic syndrome? Results from a population-based study of 27,485 people. Environ Med. 2001;58:747–52.
  • Quin LQ, Li J, Wang Y, Wang J, Xu JY, Kaneko T. The effect of nocturnal life on endocrine circadian pattern in healthy adults. Life Sci. 2003;73:2467–75.
  • Garaulet M, Madrid JA. Chronobiological aspects of nutrition, metabolic syndrome and obesity. Adv Drug Deliv Rev. 2010;62:967–78.
  • Garaulet M, Lee YC, Shen J, Parnell LD, Arnett DK, Tsai MY, . Genetic variants in human CLOCK associate with energy intake and cytokine sleep factors in overweight subjects (GOLDN population). Eur J Human Gen. 2010;18:364–9.
  • Katzenberg P, Young T, Finn L, Lin L, King DP, Takahashi JS, . A CLOCK polymorphism associated with human diurnal preferences. Sleep. 1998;21:569–76.
  • Xu Y, Toh KL, Jones CR, Shin JY, Fu YH, Ptacek LJ. Modeling of human circadian mutation yields insights into clock regulation by PER2. Cell. 2007;128:59–70.
  • Garaulet M, Sanchez-Moreno C, Smith CE, Lee YC, Nicolas F, Ordovas JM. Ghrelin, sleep reduction and evening preference: relationships to CLOCK 3111 T/C SNP and weight loss. PLoS One. 2011;6:e17435.
  • Gorbachinsky I, Akpinar H, Assimas DG. Metabolic syndrome and urologic diseases. Rev Urol. 2010;12:e157–80.
  • Buijs RM, Kraier F. The metabolic syndrome: a brain disease? J Neuroendocrinol. 2006;18:715–8.
  • Kohsaka A, Bass J. A sense of time: how molecular clocks organize metabolism. Trends Endocrinol Metab. 2007;18:1–4.
  • Froy O. The relationship between nutrition and circadian rhythms in mammals. Front Neuroendocrinol. 2007;28: 61–71.
  • Lapasky AD, Bass J, Kohasaka A, Turek FW. Sleep and circadian rhythms: key components in the regulation of energy metabolism. FEBS Lett. 2008;582:142–51.
  • Yang X, Dawnes M, Yu RT, Booboat AL, He W, Straume M, . Nuclear receptor expression links the circadian clock to metabolism. Cell. 2006;126:801–10.
  • Fonken LK, Workman JL, Walton JC, Weil ZM, Morris JS, Haim A, . Light at night increases body mass by shifting the time of food intake. Proc Natl Acad Sci USA. 2010; 107:18664–9.
  • Fung TT, Hu FB, Yu J, Spiegelman, D, Tofler GH, Willett WC, . Leisure-time physical activity, television watching, and plasma biomarkers of obesity and cardiovascular disease risk. Am J Epidemiol. 2000;152:1171–8.
  • Arbie DM, Bass J, Laposky AD, Vitaterna MH, Turek FW. Circadian timing of food intake contributes to weight gain. Obesity. 2009;17:2100–2.
  • Ruger M, Scheer FA. Effects of circadian disruption on the cardiometabolic system. Rev Endocr Metab Disord. 2009;10:245–60.
  • Garaulet M, Hernandez-Morante JJ, de Heredia F, Tebar FJ. Adiponectin; the controversial hormone. Public Health Nutr. 2007;10:1146–50.
  • Barnea M, Mador Z, Froy O. High-fat diet delays and feeding advances the circadian expression of adiponectin signaling components in mouse liver. Endocrinology. 2009; 161–8.
  • Lemmer B. The importance of circadian rhythms on drug response in hypertension and coronary heart disease—from mice and man. Pharmacol Ther. 2006;111:629–51.
  • Hamada T, Murata T, Narita K, Takahashi T, Wada Y, Kimura H, . The clinical significance of abnormal diurnal blood pressure in healthy late middle-aged and older adults. Blood Press. 2008;17:134–40.
  • Ruiz Pons M, Garcia Nieto V, Garcia MG, Garcia-Merida M, Valenzuela Hdez C, Aguirre-Jaime A. Reduced nocturnal systolic blood pressure dip in obese children. Nefrologia. 2008;28:517–24.
  • Gomez-Abelian P, Hernandez-Morento JJ, Lujan JA, Madrid JA, Garaulet M. Clock genes are implicated in the human metabolic syndrome. Int J Obes. 2008;32:121–8.
  • Ferreira I, Twisk JW, Mechelen W, Kemper HC, Stehouwer CD. Development of fatness, fitness, and lifestyle from adolescence to the age of 36 years: determinants of the metabolic syndrome in young adults: the Amsterdam growth and health longitudinal study. Arch Int Med. 2005;165:42–8.
  • Karatsoreos IN, Bhagat SM, Bloss E, Morrison JH, McEwen BS. Disruption of circadian clocks has ramifications for metabolism, brain, and behavior. Proc Natl Acad Sci USA. 2011;108:1657–62.
  • Scheer FAJL, Hilton MF, Mantzoros CS, Shea SA. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Sci USA. 2009;106: 4453–8.
  • Kripke D, Simons R, Garfinkel L, Hammond E. Short and long sleep and sleeping pills: Is increased mortality associated? Arch Gen Psychiatr. 1979;36:103–16.
  • Gallup Organization. Sleep in America. Princeton, NJ: Gallup Organization; 1995.
  • National Center for Health Statistics. Quick stats: percentage of adults who report an average of < 6 hours of sleep per 24 hour period by sex and age group—United States, 1985–2004. Morbid Mortal Wk Rep. 2005;54:933.
  • Jean-Louis G, Kripke DF, Ancoli-Israel S, Klauber MR, Sepulveda RS. Sleep duration, illumination, and activity patterns in a population sample: effects of gender and ethnicity. Biol Psychiatr. 2000;47:921–7.
  • Redline S, Kirchner HL, Quan SF, Gottlieb DJ, Kapur V, Newman A. The effects of age, sex, ethnicity, and sleep-disordered breathing in sleep architecture. Arch Int Med. 2004;164:406–18.
  • Lauderdale D, Knutson K, Yan L, Rathouz P, Hulley SB, Sidney S, . Objectively measured sleep characteristics among early middle-aged adults: the CARDIA study. Am J Epidermiol. 2006;164:5–16.
  • Tasali E, Mokhlesi B, Van Cauter E. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest. 2008; 133:496–506.
  • Abrams P, Levitt Katz LE. Metabolic effects of obesity causing disease in childhood. Curr Opin Endocrinol Diabetes Obes. 2011;18:23–7.
  • Tasali E, Leproult R, Ehrmann DA, Van Cauter E. Slow-wave sleep and the risk of type 2 diabetes in humans. Proc Natl Acad Sci USA. 2008;105:1044–9.
  • Rechtaschaffen A, Bergmann BM. Sleep deprivation in the rat by the disk-over-water method. Behav Brain Res. 1995; 69:55–63.
  • Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354: 1435–9.
  • Chin-Chance C, Polonsky KS, Schoeller D. Twenty-four hour leptin levels respond to cumulative short-term energy imbalance and predict subsequent intake. J Clin Endocrinol Metab. 2000;85:2685–91.
  • Spiegel E, Tasali E, Penev P, Van Cauter E. Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels and increased hunger and appetite. Ann Int Med. 2004;141:846–50.
  • Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index (BMI). Sleep. 2004;27: A146–7.
  • Chaput JP, Despres JP, Bouchard C, Tremblay A. Short sleep duration is associated with reduced leptin levels and increased adiposity: results from the Quebec family study. Obesity. 2007;15:253–61.
  • Hitze B, Bosy-Westphal A, Bielfeldt F, Settler V, Plachta-Danielzik S, Pfeuffer M, . Determinants and impact of sleep duration in children and adolescents: data of the Kiel Obesity Prevention Study. Eur J Clin Endocrinol. 2009; 63:739–46.
  • Nixon GM, Thompson JM, Han DY, Becroft DM, Clark PM, Robinson E, . Short sleep duration in middle childhood: risk factors and consequences. Sleep. 2008;31:71–8.
  • Rontoyanni VG, Baic S, Cooper AR. Association between nocturnal sleep duration, body fatness, and dietary intake in Greek women. Nutrition. 2007;23:773–7.
  • Littman AJ, Vitiello MV, Foster-Schubert K, Ulrich CM, Tworoger SS, Potter JD, . Sleep, ghrelin, leptin and changes in body weight during a 1-year moderate-intensity physical activity intervention. Int J Obes. 2006;31:466–78.
  • Bjorvatn B, Sagen IM, Oyane N, Waage S, Fetveit A, Pallesen S, . The association between sleep duration, body mass index and metabolic measures in the Hordaland Health Study. J Sleep Res. 2007;16:66–76.
  • Patel SR, Hu FB. Sleep duration and weight gain: a systematic review. Obesity. 2008;16:643–53.
  • Knutson KL. Sleep duration and cardiometabolic risk: a review of the epidemiologic evidence. Best Pract Res Clin Endocrinol Metab. 2010;24:731–43.
  • Morselli L, Leproult R, Balbo M, Spiegel K. Role of sleep duration in the regulation of glucose metabolism and appetite. Best Pract Res Clin Endocrinol Metab. 2010;24: 687–702.
  • Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev. 1991;12: 151–80.
  • Lewy AJ. Melatonin and human chronobiology. Cold Spring Harbor Symp Quant Biol. 2007;72:623–36.
  • Skinner DC, Malpaux B. High melatonin concentrations in third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus. Endocrinology. 1999;140:4399–405.
  • Wehr TA. A ‘clock for all seasons’ in the human brain. Prog Brain Res. 1996;111:321–42.
  • Gooley JJ, Rajaratnam SM, Brainard GC, Kronauer RE, Czeisler CA, Lockley SW. Spectral responses of the human circadian system depend on the irradiance and duration of exposure to light. Sci Transl Med. 2010;2:31–3.
  • Lockley SW, Brainard GC, Czeisler CA. High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light. J Clin Endocrinol Metab. 2003;88: 4502–5.
  • Lewy AJ, Wehr TA, Goodwin FK, Newsome DA, Markey SP. Light suppresses melatonin secretion in humans. Science. 1980;210:1267–9.
  • Rea MS, Bullough JD, Figueiro MG. Human melatonin suppression by light: a case of scotopic efficiency. Neurosci Lett. 2001;299:45–8.
  • Zisapel N. The use of melatonin for the treatment of insomnia. Biol Signal Recept. 1999;8:84–9.
  • Jan JE, Freeman RD, Fast DK. Melatonin treatment of sleep-wake cycle disorders in children and adolescents. Dev Med Child Neurol. 1999;41:491–500.
  • Bartness TJ, Wade GN. Photoperiodic control of seasonal body weight cycles in hamsters. Neurosci Biobehav Res. 1985;9:599–612.
  • Puchalski W, Lynch GR. Daily melatonin injections affect the expression of circadian rhythmicity in Djungarian hamsters kept under long-day photoperiod. Neuroendocrinology. 1988;48:280–6.
  • Puchalski W, Kliman R, Lynch GR. Differential effects of short day photoperiod on melatonin-induced adjustments in Djungarian hamsters. Life Sci. 1988;43:1005–12.
  • Elliott JA, Bartness TJ, Goldman BD. Effect of melatonin infusion duration and frequency on gonad, lipid and body mass in pinealectomized male Siberian hamsters. J Biol Rhythms. 1989;4:439–55.
  • Pan M, Song YL, Xu JM, Gan HZ. Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats. J Pineal Res. 2006;41:79–84.
  • Raskind MA, Burke BL, Crites NJ, Tapp AM, Rasmussen DD. Olanzapine-induced weight gain and increased visceral adiposity is blocked by melatonin replacement therapy in rats. Neuropsychopharmacology. 2007;32:284–8.
  • Gonzalez A, Alvarez-Garcia V, Martinez-Campa C, Mediavilla MD, Alonso-Gonzalez EJ, . In vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatonin. Curr Cancer Drug Targets. 2010;10:279–86.
  • Rasmussen DD, Boldt BM, Wilkinson CW, Yellon SM, Matsumoto AM. Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels. Endocrinology. 1999;140: 1009–12.
  • Walden-Hanson T, Mitton DR, McCants RL, Yellon SM, Wilkinson CW, Matsumoto AM, . Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology. 2000;141:487–97.
  • Rasmussen DD, Mitton DR, Larsen SA, Yellon SM. Aging-dependent changes in the effect of daily melatonin supplementation on rat metabolic and behavioral responses. J Pineal Res. 2001;31:89–94.
  • Puchalski SS, Green JN, Rasmussen DD. Melatonin effect on rat body weight regulation in response to high-fat diet at middle age. Endocrine. 2003;21:163–7.
  • Prunet-Marcassus B, Desbazeille M, Bros A, Louche K, Delagrange P, Renard P, . Melatonin reduces body weight gain in Sprague Dawley rats with diet-induced obesity. Endocrinology. 2003;144:5347–52.
  • Rios-Lugo MJ, Cano P, Jimenez-Ortega V, Fernandez-Mateos MP, Scacchi PA, Cardinali DP, . Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides, and cholesterol in normal and high fat-fed rats. J Pineal Res. 2010;49:342–8.
  • Richard D, Picard F. Brown fat biology and thermoregulations. Front Biosci. 2011;16:74–104.
  • Heldmaier G, Hoffmann K. Melatonin stimulates growth of brown adipose tissue. Nature. 1974;247:224–5.
  • Sinnamon WB, Pivorun EB. Melatonin induces hypertrophy of brown adipose tissue in Spermophilus tridecemlineatus. Cryobiology. 1981;18:603–7.
  • Viswanathan M, Hissa R, George RC. Effects of short photoperiod and melatonin treatment on thermogenesis in the Syrian hamster. J Pineal Res. 1986;3:311–21.
  • Puig-Domingo M, Guerrero JM, Menendez-Pelaez A, Reiter RJ. Melatonin specifically stimulates type-II thyroxine 51-deiodination in brown adipose tissue of Syrian hamsters. J Endocrinol. 1989;122:553–8.
  • Ricquier D. Neonatal brown adipose tissue: UCP1 and the novel uncoupling proteins. Biochem Soc Trans. 1998;26:120–3.
  • Cypess AM, Lehman S, Williams G, Tal I, Rodman D, Goldfine AB, . Identification and importance of brown adipose tissue in adult humans. N Engl J Med. 2009;360: 1509–17.
  • Saito M, Okamatsu Y, Matsushita M, Watanabe KM Yoneshiro T, Nio-Kobayashi J, . High incidence of metabolically active brown adipose tissue in healthy humans: effects of cold exposure and adiposity. Diabetes. 2009;58:1526–31.
  • Kasiske BL, O'Donnell MP, Keane WF. The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury. Hypertension. 1992;19:1110–5.
  • Agil A, Navarro-Alarcon M, Ruiz R, Abuhamadah S, El-Mir MY, Fernandez-Vasquez G. Beneficial effects of melatonin on obesity and lipid profile in young Zucker diabetic fatty rats. J Pineal Res. 2011;50:207–12.
  • Tamura H, Nakamura Y, Narimatsu A, Yamagata Y, Takasaki A, Reiter RJ, . Melatonin treatment in peri- and postmenopausal women elevates serum high density lipoprotein cholesterol levels without influencing total cholesterol. J Pineal Res. 2008;45:101–5.
  • Nduhirabandi F, Du Toit EF, Blackhurst D, Marais D, Lochner A. Chronic melatonin consumption prevents obesity-related metabolic abnormalities and protects the heart against myocardial ischemia and reperfusion injury in a prediabetic model of diet-induced obesity. J Pineal Res. 2011; 50:171–82.
  • Kozirog M, Poliwczak AR, Duchnowicz P, Koter-Michalak M, Sikora J, Broncel M. Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. J Pineal Res. 2011;50:261–6.
  • Cagnacci A, Cannoletta M, Renzi A, Baldassari F, Arangino S, Volpe A. Prolonged melatonin administration decreases nocturnal blood pressure in women. Am J Hypertens. 2005;18(12Pt1):1614–8.
  • Scheer FA. Potential use of melatonin as adjunct antihypertensive therapy. Am J Hypertens. 2005;18(12pt1):1619–20.
  • Reiter RJ, Tan DX, Korkmaz A. The circadian melatonin rhythm and its modulation: possible impact on hypertension. J Hypertens Suppl. 2009;27:S17–20.
  • Simko F, Pechanova O. Potential roles of melatonin and chronotherapy among the new trends in hypertension treatment. J Pineal Res. 2009;47:127–33.
  • Dominguez-Rodriguez A, Abreu-Gonzalez P, Reiter RJ. Clinical aspects of melatonin in the acute coronary syndrome. Curr Vasc Pharmacol. 2009;7:367–73.
  • Dominguez-Rodriguez A, Abreu-Gonzalez P, Sanchez-Sanchez JJ, Kaski JC, Reiter RJ. Melatonin and circadian biology of cardiovascular disease. J Pineal Res. 2010;49:14–22.
  • Reiter RJ, Manchester LC, Fuentes-Broto L, Tan DX. Cardiac hypertrophy and remodeling: pathophysiological consequences and protective effects of melatonin. J Hypertens. 2010;28 Suppl 1:S7–12.
  • Forman K, Vara E, Garcia C, Kireev R, Cuesta S, Acuna-Castroviejo D, . Beneficial effects of melatonin on cardiological alterations in a murine model of accelerated aging. J Pineal Res. 2010;49:312–20.
  • Reiter RJ, Richardson BA, Johnson LY, Ferguson DN, Dinh DT. Pineal melatonin rhythm: reduction in aging Syrian hamsters. Science. 1980;210:1372–3.
  • Reiter RJ, Craft CM, Johnson LYJ, King TS, Richardson BA, Vaughan GM, . Age-associated reduction in nocturnal pineal melatonin levels in female rats. Endocrinology. 1981;109:1295–7.
  • Sack RL, Lewy AJ, Erb DL, Vollmer WM, Singer CM. Human melatonin production decreases with age. J Pineal Res. 1986;3:379–88.
  • Pang SF, Tsang CW, Hong GX, Yip PC, Tang PL, Brown GM. Fluctuation of blood melatonin concentrations with age: result of changes in pineal melatonin secretion. J Pineal Res. 1990;8:179–82.
  • Bass J, Turek FW. Sleepiness in America: a pathway to obesity and the metabolic syndrome. Arch Int Med. 2005;165: 15–16.
  • Maury E, Ramsey KM, Bass J. Circadian rhythms and metabolic syndrome: from experimental genetics to human disease. Circ Res. 2010;106:447–62.
  • Cardinali DP, Cano P, Jimenez-Ortega V, Esquifino AI. Melatonin and the metabolic syndrome: physiopathologic and therapeutic implications. Neuroendocrinology. 2011; 93:133–42.
  • Vorona RD, Winn MP, Babineau TW, Eng BP, Felman HR, Ware C. Overweight and obese patients in a primary care population report less sleep than patients with normal body mass index. Arch Int Med. 2005;165: 25–30.
  • Erren TC, Falaturi P, Reiter RJ. Research into the chronodisruption-cancer theory: the imperative for causal clarification and the danger of causal reductionism. Neuroendocrinol Lett. 2010;31:1–3.
  • Erren TC, Reiter RJ. A generalized theory of carcinogenesis due to chronodisruption. Neuroendocrinol Lett. 2008;29: 815–21.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.